Famitinib Completed Phase 3 Trials for Recurrent Colorectal Cancer / Metastatic Colorectal Cancer (CRC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02390947Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma(FACT)